🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Some experts said the demand for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

According to TikTok, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The organization stated it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

Within minutes of joining one community, a seller shared contact information, where most purchases occur. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, messages display black plastic parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service said it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially significant medical dangers”.